CCL5 and neoplasm: CCL5 promotes the production of immunosuppressive myeloid cells and TAMs, and immunosuppressive myeloid cells reduce tumor-infiltrating cytotoxic CD8+ T cells and elevate regulatory T cells in the tumor-draining lymph nodes, which leaves the TME in an immunosuppressed state [68].